1. Home
  2. Detail

@anjum.khan143: Te pese mera ustad lutty ga hor koi nei #teamsargodha #sargodhawaly #anjumzfame #anjumkhan013 #like #viral #funny

A4-ANJUM.KHAN
A4-ANJUM.KHAN
Open In TikTok:
Region: PK
Monday 02 December 2019 18:00:41 GMT
1799
168
7
7

Music

Download

No Watermark .mp4 (3.14MB) No Watermark(HD) .mp4 (3.14MB) Watermark .mp4 (2.54MB) Music .mp3

Comments

rizwanrajpoot56
RIZWAN TIK TOK💓 :
kml
2019-12-02 19:03:46
3
rizwanrajpoot56
RIZWAN TIK TOK💓 :
hhhhhh
2019-12-02 19:03:42
2
arslankhan0629
Arslankhan0629 :
hahahahah
2019-12-03 17:01:57
0
arslankhan0629
Arslankhan0629 :
🤣🤣🤣🤣🤣🤣🤣
2019-12-03 17:02:03
0
foujijunaid001
00 :
hahaha
2019-12-06 14:47:07
0
liaqatkhan001
It’s Müśä 👉🏻🔥 :
hahahaha
2019-12-14 23:22:06
0
gaaabl1
gaaabl1 :
😂😂😂😂
2019-12-20 03:34:47
0
To see more videos from user @anjum.khan143, please go to the Tikwm homepage.

Other Videos

𝙇𝘼𝙆𝙎𝘼𝙉𝘼 𝙈𝙐𝙏𝙄𝘼𝙍𝘼 𝙔𝘼𝙉𝙂 𝙏𝙀𝙍𝙎𝙄𝙈𝙋𝘼𝙉 𝘽𝘼𝙄𝙆. #vibespantai #malamhari #aesthetic #xzycba #galau #pleasurebeach
𝙇𝘼𝙆𝙎𝘼𝙉𝘼 𝙈𝙐𝙏𝙄𝘼𝙍𝘼 𝙔𝘼𝙉𝙂 𝙏𝙀𝙍𝙎𝙄𝙈𝙋𝘼𝙉 𝘽𝘼𝙄𝙆. #vibespantai #malamhari #aesthetic #xzycba #galau #pleasurebeach
@Areen #اكسلبور #ثانوي #4u #explore
@Areen #اكسلبور #ثانوي #4u #explore
😅🖤 #foryou #foryoupage #uae🇦🇪 #arab #arif_73 #ctg
😅🖤 #foryou #foryoupage #uae🇦🇪 #arab #arif_73 #ctg
I had to #leonkennedy #leonkennedyedit #residentevil #residentevil4 #residenteviledit #leonkennedyre4
I had to #leonkennedy #leonkennedyedit #residentevil #residentevil4 #residenteviledit #leonkennedyre4
#عبارات #fyp #صعدوه_اكسبلوور #عنيد_يافع😔🥀
#عبارات #fyp #صعدوه_اكسبلوور #عنيد_يافع😔🥀
Covid Vaccine Victims Get Huge Payout from UK Government #sideeffects. In the process of approving medications, regulatory agencies such as the FDA carefully evaluate the risk and benefit ratio of a drug based on clinical trial data and other evidence. While a small number of people may experience serious side effects from a medication, it can still be approved for use if the overall benefit of the drug outweighs the potential risks for the majority of patients. Here's how this risk-benefit analysis works: Clinical trial data: Before a medication is approved for use, it undergoes rigorous testing in clinical trials to evaluate its safety and effectiveness. These trials involve thousands of participants who are closely monitored for side effects and adverse reactions. While most participants may experience mild or tolerable side effects, a small number of individuals may experience more serious or severe adverse events. Risk assessment: Regulatory agencies assess the frequency and severity of adverse events observed during clinical trials to determine the overall risk profile of the medication. They consider factors such as the severity of the condition being treated, the availability of alternative treatments, and the potential benefits of the drug in reducing symptoms, improving quality of life, or prolonging survival. Benefit evaluation: Regulatory agencies also evaluate the potential benefits of the medication in relation to its risks. They consider factors such as the magnitude of treatment effect observed in clinical trials, the clinical significance of the outcomes measured, and the overall impact of the drug on patient health and well-being. Risk-benefit analysis: Based on the assessment of both the risks and benefits, regulatory agencies make decisions about whether to approve a medication for use. If the overall benefit of the drug is deemed to outweigh the potential risks for the majority of patients, it may be approved with appropriate warnings, precautions, and monitoring requirements to mitigate the risk of adverse events. #covid19 #vaccine
Covid Vaccine Victims Get Huge Payout from UK Government #sideeffects. In the process of approving medications, regulatory agencies such as the FDA carefully evaluate the risk and benefit ratio of a drug based on clinical trial data and other evidence. While a small number of people may experience serious side effects from a medication, it can still be approved for use if the overall benefit of the drug outweighs the potential risks for the majority of patients. Here's how this risk-benefit analysis works: Clinical trial data: Before a medication is approved for use, it undergoes rigorous testing in clinical trials to evaluate its safety and effectiveness. These trials involve thousands of participants who are closely monitored for side effects and adverse reactions. While most participants may experience mild or tolerable side effects, a small number of individuals may experience more serious or severe adverse events. Risk assessment: Regulatory agencies assess the frequency and severity of adverse events observed during clinical trials to determine the overall risk profile of the medication. They consider factors such as the severity of the condition being treated, the availability of alternative treatments, and the potential benefits of the drug in reducing symptoms, improving quality of life, or prolonging survival. Benefit evaluation: Regulatory agencies also evaluate the potential benefits of the medication in relation to its risks. They consider factors such as the magnitude of treatment effect observed in clinical trials, the clinical significance of the outcomes measured, and the overall impact of the drug on patient health and well-being. Risk-benefit analysis: Based on the assessment of both the risks and benefits, regulatory agencies make decisions about whether to approve a medication for use. If the overall benefit of the drug is deemed to outweigh the potential risks for the majority of patients, it may be approved with appropriate warnings, precautions, and monitoring requirements to mitigate the risk of adverse events. #covid19 #vaccine

About

Legal